July 17, 2012 — Panasonic announced a new 3-D medical-grade 32-inch class monitor, the EJ-MDA32U-K. The new 3-D monitor is fully compliant with medical equipment standards, delivers exceptional 2-D and 3-D image quality, and can display multiple images from various sources at once. These combined features, paired with Panasonic’s renowned reliability, make the new monitor ideal for use in the surgical bubble.

July 17, 2012 — New analysis from Frost & Sullivan, “European Data Storage Market in Healthcare,” finds that the market earned revenues of $1,011.4 million in 2010 and estimates this to reach $2,473 million in 2017. The research covers hospital IT, research and imaging segments.

July 17, 2012 — Arterial Remodeling Technologies (ART) reported that they have achieved a medical milestone with its Arterial Remodeling Transient DIsmantling Vascular Angioplasty (ARTDIVA) clinical trial: The successful first-in-human implantation of its novel biodegradable stent into an 61-year-old male who was suffering from a blocked coronary artery and needed a percutaneous coronary intervention (PCI).


As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease increase, the usage of cardio and endovascular stents continues to grow. Interventional cardiologists and registered nurses in the U.S. were recently asked about their perceptions and attitudes regarding current percutaneous coronary interventional (PCI) procedures and devices. They were also asked their stent brand and drug type preferences. In a statistically significant survey, they divulged which procedures and manufactures they preferred. This window into micro level stent usage offers informed insights into the overall market and reveals how dynamics between medical organizations and device manufacturers contribute to market trends.

July 16, 2012 — TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its unique Glider PTCA balloon catheter.

Mercator MedSystems, a medical technology company whose platform Micro-Infusion Catheter technology announced preliminary results of its DANCE clinical trial that continues to follow patients at the University of California, San Francisco (UCSF) and  San Francisco VA Medical Center. The technology offers catheter-guided, microfluid injection systems for site-specific, nonsystemic delivery of therapeutic agents directly across any peripheral or coronary blood vessel to treat peripheral vascular diseases, cancer, heart attacks, and other life-threatening diseases and disorders.


July 16, 2012 — The American College of Cardiology (ACC) and the American College of Radiology (ACR) are warning that the extreme cuts to funding for medical imaging scans in the 2013 Medicare Physician Fee Schedule Proposed Rule are unnecessary, unfounded and will undermine patient care.

July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable scaffold. A total of 26 patients have been enrolled and there are no major adverse coronary events (MACE) reported to date.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now